WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are... disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases
more
Regulations by the Minister of Health (the “Minister”) Governing The Control and Abatement of the Spread and Eradication of the Ebola Virus Disease (EVD) in Liberia, hereinafter
Overview of Community-Based Integrated Management of Childhood Illnesses
Further analysis of the 1996, 2001, and 2006 Demographic and Health Surveys Data